Parker S. Ruth
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Parker S. Ruth has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Julie Muccini
Department of Radiology, Stanford University, Stanford, California, USA
4 shared publications - Scott L. Delp
Department of Bioengineering, Stanford University, Stanford, California, USA
4 shared publications - Constance de Monts
Department of Neurology, Stanford Medicine, Stanford, CA
3 shared publications - John W. Day
Department of Neurology, Stanford Medicine, Stanford, CA
3 shared publications - Scott D. Uhlrich
University of Utah
3 shared publications - Shelby Vogt-Domke
Department of Neurology, Stanford Medicine, Stanford, CA
3 shared publications
Latest Publications
- Open Access
Deep learning models detect neuromuscular disease and quantify functional impairment from video-derived biomechanics data
Measurements of human movement are critical for evaluating patients with neuromuscular diseases. However, current clinical tools are limited in sensitivity and can fail to detect the full spectrum of movement changes patients may exhibit. These limitations can obscure early signs of decline, delaying interventions that could preserve function and independence. OpenCap––a smartphone application that performs video-based markerless motion capture––can help address this gap by enabling scalable, out-of-lab measurements of human movement. Here, we present a method for both detecting disease and quantifying the severity of impaired movement from smartphone videos of a patient’s motion. We used OpenCap to measure kinematics from 337 individuals with diagnoses spanning 12 rare, genetically-defined neuromuscular diseases and 78 age-matched healthy controls. Our dataset is the largest existing publicly available resource of body segment kinematics for this class of diseases. These data were collected in neuromuscular clinics during regular clinic visits as well as at conferences and community events across the United States. We trained deep learning models on these kinematic time series to differentiate between participants with neuromuscular disease and controls (AUROC = 0.97 [0.93-1.00]). We also developed a movement impairment severity score that correlates with both participants’ ratings of their own functional abilities (ρ= -0.81, p<0.001) and existing clinical tests of movement capabilities such as run speed (ρ= -0.83, p<0.001). Our methods for detecting disease and deriving quantitative biomarkers of movement impairment from smartphone videos have the potential to complement clinical assessments, inform screening protocols, and improve clinical trial endpoints.
Open AccessDeep learning models detect neuromuscular disease and quantify functional impairment from video-derived biomechanics data
Measurements of human movement are critical for evaluating patients with neuromuscular diseases. However, current clinical tools are limited in sensitivity and can fail to detect the full spectrum of movement changes patients may exhibit. These limitations can obscure early signs of decline, delaying interventions that could preserve function and independence. OpenCap––a smartphone application that performs video-based markerless motion capture––can help address this gap by enabling scalable, out-of-lab measurements of human movement. Here, we present a method for both detecting disease and quantifying the severity of impaired movement from smartphone videos of a patient’s motion. We used OpenCap to measure kinematics from 337 individuals with diagnoses spanning 12 rare, genetically-defined neuromuscular diseases and 78 age-matched healthy controls. Our dataset is the largest existing publicly available resource of body segment kinematics for this class of diseases. These data were collected in neuromuscular clinics during regular clinic visits as well as at conferences and community events across the United States. We trained deep learning models on these kinematic time series to differentiate between participants with neuromuscular disease and controls (AUROC = 0.97 [0.93-1.00]). We also developed a movement impairment severity score that correlates with both participants’ ratings of their own functional abilities (ρ= -0.81, p<0.001) and existing clinical tests of movement capabilities such as run speed (ρ= -0.83, p<0.001). Our methods for detecting disease and deriving quantitative biomarkers of movement impairment from smartphone videos have the potential to complement clinical assessments, inform screening protocols, and improve clinical trial endpoints.
- Open Access
StaBLE: digital metrics capture balance performance across a wide spectrum of balance tasks and abilities
Balance is fundamental to mobility and independence, yet it remains difficult to measure in a way that is both clinically meaningful and feasible for widespread adoption. There is a need for more quantitative, objective, and accessible balance assessments. To this end, we created the Stanford Balance Level Evaluation (StaBLE), a battery of 18 balance-challenging tasks and accompanying digital performance metrics computed from video that aimed to capture widely ranging balance abilities across 180 participants. We validated the StaBLE score against existing clinical scales and found that it correlated with age (ρ = -0.76, p<0.001), the Activities-Specific Balance Confidence Scale (ρ = 0.60, p<0.001), a Mini-Balance Evaluation Systems Test task (τ=0.55, p<0.001), 4-Stage Balance Test (τ = 0.55, p<0.001), and Short Physical Performance Battery (τ =0.57, p<0.001). StaBLE overcame ceiling effects in these existing scales and had a different underlying distribution for those identified at risk of falling and not (KS: 0.67, p<0.001). To reduce the time it takes to perform the test, we identified subsets of balance tasks that best predicted the StaBLE score across different populations. Together, our dataset, balance assessment protocol, and performance-based score demonstrate the validity of digital measures of balance.
Open AccessStaBLE: digital metrics capture balance performance across a wide spectrum of balance tasks and abilities
Balance is fundamental to mobility and independence, yet it remains difficult to measure in a way that is both clinically meaningful and feasible for widespread adoption. There is a need for more quantitative, objective, and accessible balance assessments. To this end, we created the Stanford Balance Level Evaluation (StaBLE), a battery of 18 balance-challenging tasks and accompanying digital performance metrics computed from video that aimed to capture widely ranging balance abilities across 180 participants. We validated the StaBLE score against existing clinical scales and found that it correlated with age (ρ = -0.76, p<0.001), the Activities-Specific Balance Confidence Scale (ρ = 0.60, p<0.001), a Mini-Balance Evaluation Systems Test task (τ=0.55, p<0.001), 4-Stage Balance Test (τ = 0.55, p<0.001), and Short Physical Performance Battery (τ =0.57, p<0.001). StaBLE overcame ceiling effects in these existing scales and had a different underlying distribution for those identified at risk of falling and not (KS: 0.67, p<0.001). To reduce the time it takes to perform the test, we identified subsets of balance tasks that best predicted the StaBLE score across different populations. Together, our dataset, balance assessment protocol, and performance-based score demonstrate the validity of digital measures of balance.
- Open Access
- 10 September 2026
- Published by Springer Nature in npj Digital Medicine
Vascular waveform analysis using Bayesian pulse deconvolution
Vascular waveforms, which measure pulsatile flow in blood vessels, are widely used to measure vital signs, diagnose conditions, and predict long-term health outcomes. Analyzing vascular waveforms depends on three fundamentally interdependent tasks: signal filtering, pulse timing detection, and pulse shape extraction. We hypothesized that Bayesian pulse deconvolution can achieve improved performance on all three tasks by solving them jointly. This method uses an analytical, generative model of vascular waveforms with priors informed by physical and biological domain knowledge. In simulations, Bayesian pulse deconvolution achieves better performance on all tasks compared with existing algorithms: 84% reduction of median filtering error, 60% reduction in pulse timing error, and 85% reduction in shape extraction error. The advantages in simulations extend to human recordings of photoplethysmography waveforms. Taking real-time-synchronized electrocardiogram R-R intervals as a proxy ground truth, Bayesian pulse deconvolution achieves 40% lower pulse interval estimation error (RMSE = 5.1 ms) compared with typical algorithms (RMSE = 8.3 ms, p = 1e–10). By extracting more accurate and informative insights from vascular waveforms, Bayesian pulse deconvolution could advance a wide array of health technologies that rely on interpreting signals from blood vessels.
- 10 September 2026
- Published by Springer Nature in npj Digital Medicine
Open AccessVascular waveform analysis using Bayesian pulse deconvolution
Vascular waveforms, which measure pulsatile flow in blood vessels, are widely used to measure vital signs, diagnose conditions, and predict long-term health outcomes. Analyzing vascular waveforms depends on three fundamentally interdependent tasks: signal filtering, pulse timing detection, and pulse shape extraction. We hypothesized that Bayesian pulse deconvolution can achieve improved performance on all three tasks by solving them jointly. This method uses an analytical, generative model of vascular waveforms with priors informed by physical and biological domain knowledge. In simulations, Bayesian pulse deconvolution achieves better performance on all tasks compared with existing algorithms: 84% reduction of median filtering error, 60% reduction in pulse timing error, and 85% reduction in shape extraction error. The advantages in simulations extend to human recordings of photoplethysmography waveforms. Taking real-time-synchronized electrocardiogram R-R intervals as a proxy ground truth, Bayesian pulse deconvolution achieves 40% lower pulse interval estimation error (RMSE = 5.1 ms) compared with typical algorithms (RMSE = 8.3 ms, p = 1e–10). By extracting more accurate and informative insights from vascular waveforms, Bayesian pulse deconvolution could advance a wide array of health technologies that rely on interpreting signals from blood vessels.
- Open Access
Vascular waveform analysis using Bayesian pulse deconvolution
Vascular waveforms, which measure bulk flow in blood vessels, are widely used to measure vital signs, diagnose conditions, and predict long-term health outcomes. Analyzing vascular waveforms depends on three fundamentally interdependent tasks: signal filtering, pulse timing detection, and pulse shape extraction. We hypothesized that Bayesian pulse deconvolution can achieve improved performance on all three tasks by solving them jointly. This method uses an analytical, generative model of vascular waveforms with priors informed by physical and biological domain knowledge. In simulations, Bayesian pulse deconvolution achieves better performance on all tasks compared with existing algorithms: 90% reduction of median filtering error, 60% reduction in pulse timing error, and 85% reduction in shape extraction error. The advantages in simulations extend to human recordings of photoplethysmography waveforms. Taking real time-synchronized electrocardiogram R-R intervals as a proxy ground truth, Bayesian pulse deconvolution achieves 40% lower pulse interval estimation error (RMSE = 5.1 ms) compared with typical algorithms (RMSE = 8.3 ms, p=1e–10). By extracting more accurate and informative insights from vascular waveforms, Bayesian pulse deconvolution could advance a wide array of health technologies that rely on interpreting signals from blood vessels.
Open AccessVascular waveform analysis using Bayesian pulse deconvolution
Vascular waveforms, which measure bulk flow in blood vessels, are widely used to measure vital signs, diagnose conditions, and predict long-term health outcomes. Analyzing vascular waveforms depends on three fundamentally interdependent tasks: signal filtering, pulse timing detection, and pulse shape extraction. We hypothesized that Bayesian pulse deconvolution can achieve improved performance on all three tasks by solving them jointly. This method uses an analytical, generative model of vascular waveforms with priors informed by physical and biological domain knowledge. In simulations, Bayesian pulse deconvolution achieves better performance on all tasks compared with existing algorithms: 90% reduction of median filtering error, 60% reduction in pulse timing error, and 85% reduction in shape extraction error. The advantages in simulations extend to human recordings of photoplethysmography waveforms. Taking real time-synchronized electrocardiogram R-R intervals as a proxy ground truth, Bayesian pulse deconvolution achieves 40% lower pulse interval estimation error (RMSE = 5.1 ms) compared with typical algorithms (RMSE = 8.3 ms, p=1e–10). By extracting more accurate and informative insights from vascular waveforms, Bayesian pulse deconvolution could advance a wide array of health technologies that rely on interpreting signals from blood vessels.
- 28 August 2025
- Published by Massachusetts Medical Society in NEJM AI
- Vol. 2 (9)
Video-Based Biomechanical Analysis Captures Disease-Specific Movement Signatures of Different Neuromuscular Diseases
Assessing human movement is essential for diagnosing and monitoring movement-related conditions like neuromuscular disorders. Timed function tests (TFTs) are among the most widespread types of assessments due to their speed and simplicity, but they cannot capture disease-specific movement patterns. Conversely, biomechanical analysis can produce sensitive disease-specific biomarkers, but it is traditionally confined to laboratory settings. Recent advances in smartphone video–based biomechanical analysis enable the quantification of three-dimensional movement with the ease and speed required for clinical settings. However, the potential of this technology to offer more sensitive assessments of human function than TFTs remains untested. To compare video-based analysis with TFTs, we collected an observational dataset from 129 individuals: 28 with facioscapulohumeral muscular dystrophy, 58 with myotonic dystrophy, and 43 controls with no diagnosed neuromuscular condition. We used OpenCap, a free open-source software tool, to capture smartphone video–based biomechanics of nine different movements in a median time of 16 minutes per participant. From these recordings, we extracted 34 interpretable movement features. Using these features, we evaluated the ability of video-based biomechanics to reproduce four TFTs (10-meter walk, 10-meter run, timed up-and-go, and 5-times sit-to-stand) while capturing additional disease-specific signatures of movement. Video-based biomechanical analysis reproduced all four TFTs (r>0.98) with similar test–retest reliability. In addition, video metrics outperformed TFTs at disease classification (P=0.021). Unlike TFTs, video-based biomechanical analysis identified disease-specific signatures of movement, such as differences in gait kinematics, that are not evident in TFTs. Video-based biomechanical analysis can complement existing functional movement assessments by capturing more sensitive, disease-specific outcomes from human movement. This technology enables digital health solutions for assessing and monitoring motor function, complementing traditional clinical outcome measures to enhance care, management, and clinical trial design for movement-related conditions. (Funded by the Wu Tsai Human Performance Alliance and others.)
- 28 August 2025
- Published by Massachusetts Medical Society in NEJM AI
- Vol. 2 (9)
Video-Based Biomechanical Analysis Captures Disease-Specific Movement Signatures of Different Neuromuscular Diseases
Assessing human movement is essential for diagnosing and monitoring movement-related conditions like neuromuscular disorders. Timed function tests (TFTs) are among the most widespread types of assessments due to their speed and simplicity, but they cannot capture disease-specific movement patterns. Conversely, biomechanical analysis can produce sensitive disease-specific biomarkers, but it is traditionally confined to laboratory settings. Recent advances in smartphone video–based biomechanical analysis enable the quantification of three-dimensional movement with the ease and speed required for clinical settings. However, the potential of this technology to offer more sensitive assessments of human function than TFTs remains untested. To compare video-based analysis with TFTs, we collected an observational dataset from 129 individuals: 28 with facioscapulohumeral muscular dystrophy, 58 with myotonic dystrophy, and 43 controls with no diagnosed neuromuscular condition. We used OpenCap, a free open-source software tool, to capture smartphone video–based biomechanics of nine different movements in a median time of 16 minutes per participant. From these recordings, we extracted 34 interpretable movement features. Using these features, we evaluated the ability of video-based biomechanics to reproduce four TFTs (10-meter walk, 10-meter run, timed up-and-go, and 5-times sit-to-stand) while capturing additional disease-specific signatures of movement. Video-based biomechanical analysis reproduced all four TFTs (r>0.98) with similar test–retest reliability. In addition, video metrics outperformed TFTs at disease classification (P=0.021). Unlike TFTs, video-based biomechanical analysis identified disease-specific signatures of movement, such as differences in gait kinematics, that are not evident in TFTs. Video-based biomechanical analysis can complement existing functional movement assessments by capturing more sensitive, disease-specific outcomes from human movement. This technology enables digital health solutions for assessing and monitoring motor function, complementing traditional clinical outcome measures to enhance care, management, and clinical trial design for movement-related conditions. (Funded by the Wu Tsai Human Performance Alliance and others.)
- Open Access
Video-based biomechanical analysis captures disease-specific movement signatures of different neuromuscular diseases
Background: Assessing human movement is essential for diagnosing and monitoring movement-related conditions like neuromuscular disorders. Timed function tests (TFTs) are among the most widespread assessments due to their speed and simplicity, but they cannot capture disease-specific movement patterns. Conversely, biomechanical analysis can produce sensitive disease-specific biomarkers but is traditionally confined to laboratory settings. Recent advances in smartphone video-based biomechanical analysis enable quantification of 3D movement with the ease and speed required for clinical settings. However, the potential of this technology to offer more sensitive assessments of human function than TFTs remains untested. Methods: To compare video-based analysis against TFTs, we collected an observational dataset from 129 individuals: 28 with facioscapulohumeral muscular dystrophy, 58 with myotonic dystrophy, and 43 controls with no diagnosed neuromuscular condition. We used OpenCap, a free open-source software tool, to capture smartphone video-based biomechanics of nine different movements in a median time of 16 minutes per participant. From these recordings we extracted 34 interpretable movement features. Using these features, we evaluated the ability of video-based biomechanics to reproduce four TFTs (10-meter walk, 10-meter run, timed up-and-go, and 5-time sit-to-stand) while capturing additional disease-specific signatures of movement. Results: Video-based biomechanical analysis reproduced all four TFTs (r > 0.98) with similar test-retest reliability. In addition, video metrics outperformed TFTs at disease classification (p = 0.021). Unlike TFTs, video-based biomechanical analysis identified disease-specific signatures of movement such as differences in gait kinematics that are not evident in TFTs. Conclusion: Video-based biomechanical analysis can complement existing functional movement assessments by capturing more sensitive, disease-specific outcomes from human movement. This technology enables digital health solutions for assessing and monitoring motor function, complementing traditional clinical outcome measures to enhance care, management, and clinical trial design for movement-related conditions. Description: This study demonstrates that smartphone video-based biomechanical analysis can accurately replicate traditional timed function tests (TFTs) — commonly used to diagnose and assess movement-related conditions like neuromuscular disorders — while also capturing disease-specific movement patterns that TFTs fail to detect. By enabling sensitive and interpretable assessments in clinical settings, this approach offers a scalable and objective tool to enhance diagnosis, monitoring, and clinical trial design for neuromuscular disorders.
Open AccessVideo-based biomechanical analysis captures disease-specific movement signatures of different neuromuscular diseases
Background: Assessing human movement is essential for diagnosing and monitoring movement-related conditions like neuromuscular disorders. Timed function tests (TFTs) are among the most widespread assessments due to their speed and simplicity, but they cannot capture disease-specific movement patterns. Conversely, biomechanical analysis can produce sensitive disease-specific biomarkers but is traditionally confined to laboratory settings. Recent advances in smartphone video-based biomechanical analysis enable quantification of 3D movement with the ease and speed required for clinical settings. However, the potential of this technology to offer more sensitive assessments of human function than TFTs remains untested. Methods: To compare video-based analysis against TFTs, we collected an observational dataset from 129 individuals: 28 with facioscapulohumeral muscular dystrophy, 58 with myotonic dystrophy, and 43 controls with no diagnosed neuromuscular condition. We used OpenCap, a free open-source software tool, to capture smartphone video-based biomechanics of nine different movements in a median time of 16 minutes per participant. From these recordings we extracted 34 interpretable movement features. Using these features, we evaluated the ability of video-based biomechanics to reproduce four TFTs (10-meter walk, 10-meter run, timed up-and-go, and 5-time sit-to-stand) while capturing additional disease-specific signatures of movement. Results: Video-based biomechanical analysis reproduced all four TFTs (r > 0.98) with similar test-retest reliability. In addition, video metrics outperformed TFTs at disease classification (p = 0.021). Unlike TFTs, video-based biomechanical analysis identified disease-specific signatures of movement such as differences in gait kinematics that are not evident in TFTs. Conclusion: Video-based biomechanical analysis can complement existing functional movement assessments by capturing more sensitive, disease-specific outcomes from human movement. This technology enables digital health solutions for assessing and monitoring motor function, complementing traditional clinical outcome measures to enhance care, management, and clinical trial design for movement-related conditions. Description: This study demonstrates that smartphone video-based biomechanical analysis can accurately replicate traditional timed function tests (TFTs) — commonly used to diagnose and assess movement-related conditions like neuromuscular disorders — while also capturing disease-specific movement patterns that TFTs fail to detect. By enabling sensitive and interpretable assessments in clinical settings, this approach offers a scalable and objective tool to enhance diagnosis, monitoring, and clinical trial design for neuromuscular disorders.
- Open Access
- 16 February 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (2) , e0000185
Implementation of an interactive mobile application to pilot a rapid assay to detect HIV drug resistance mutations in Kenya
Usability is an overlooked aspect of implementing lab-based assays, particularly novel assays in low-resource-settings. Esoteric instructions can lead to irreproducible test results and patient harm. To address these issues, we developed a software application based on “Aquarium”, a laboratory-operating system run on a computer tablet that provides step-by-step digital interactive instructions, protocol management, and sample tracking. Aquarium was paired with a near point-of-care HIV drug resistance test, “OLA-Simple”, that detects mutations associated with virologic failure. In this observational study we evaluated the performance of Aquarium in guiding untrained users through the multi-step laboratory protocol with little supervision. To evaluate the training by Aquarium software we conducted a feasibility study in a laboratory at Coptic Hope Center in Nairobi, Kenya. Twelve volunteers who were unfamiliar with the kit performed the test on blinded samples (2 blood specimens; 5 codons/sample). Steps guided by Aquarium included: CD4+ T-Cell separation, PCR, ligation, detection, and interpretation of test results. Participants filled out a short survey regarding their demographics and experience with the software and kit. None of the laboratory technicians had prior experience performing CD4+ separation and 7/12 had no experience performing laboratory-based molecular assays. 12/12 isolated CD4+ T cells from whole blood with yields comparable to isolations performed by trained personnel. The OLA-Simple workflow was completed by all, with genotyping results interpreted correctly by unaided-eye in 108/120 (90%) and by software in 116/120 (97%) of codons analyzed. In the surveys, participants favorably assessed the use of software guidance. The Aquarium digital instructions enabled first-time users in Kenya to complete the OLA-simple kit workflow with minimal training. Aquarium could increase the accessibility of laboratory assays in low-resource-settings and potentially standardize implementation of clinical laboratory tests.
- 16 February 2022
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 2 (2) , e0000185
Open AccessImplementation of an interactive mobile application to pilot a rapid assay to detect HIV drug resistance mutations in Kenya
Usability is an overlooked aspect of implementing lab-based assays, particularly novel assays in low-resource-settings. Esoteric instructions can lead to irreproducible test results and patient harm. To address these issues, we developed a software application based on “Aquarium”, a laboratory-operating system run on a computer tablet that provides step-by-step digital interactive instructions, protocol management, and sample tracking. Aquarium was paired with a near point-of-care HIV drug resistance test, “OLA-Simple”, that detects mutations associated with virologic failure. In this observational study we evaluated the performance of Aquarium in guiding untrained users through the multi-step laboratory protocol with little supervision. To evaluate the training by Aquarium software we conducted a feasibility study in a laboratory at Coptic Hope Center in Nairobi, Kenya. Twelve volunteers who were unfamiliar with the kit performed the test on blinded samples (2 blood specimens; 5 codons/sample). Steps guided by Aquarium included: CD4+ T-Cell separation, PCR, ligation, detection, and interpretation of test results. Participants filled out a short survey regarding their demographics and experience with the software and kit. None of the laboratory technicians had prior experience performing CD4+ separation and 7/12 had no experience performing laboratory-based molecular assays. 12/12 isolated CD4+ T cells from whole blood with yields comparable to isolations performed by trained personnel. The OLA-Simple workflow was completed by all, with genotyping results interpreted correctly by unaided-eye in 108/120 (90%) and by software in 116/120 (97%) of codons analyzed. In the surveys, participants favorably assessed the use of software guidance. The Aquarium digital instructions enabled first-time users in Kenya to complete the OLA-simple kit workflow with minimal training. Aquarium could increase the accessibility of laboratory assays in low-resource-settings and potentially standardize implementation of clinical laboratory tests.